Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Respiratory Viral Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Large-scale testing (Phase 3)Study completedNCT00525044
What this trial is testing

Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat

Who this might be right for
Pharyngitis
Boehringer Ingelheim 249
Testing effectiveness (Phase 2)Active Not RecruitingNCT04488081
What this trial is testing

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Who this might be right for
COVID-19
QuantumLeap Healthcare Collaborative 1,500
Early research (Phase 1)Looking for participantsNCT07645534
What this trial is testing

Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

Who this might be right for
InfluenzaAcute Respiratory Viral Infections
Valenta Pharm JSC 36
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableStudy completedNCT05676047
What this trial is testing

Cognitive Rehabilitation for Long COVID

Who this might be right for
Long COVID
McMaster University 100
Not applicableWithdrawnNCT04456426
What this trial is testing

Characteristics of Patients With COVID-19 in Meta State, Colombia

Who this might be right for
COVIDSARS-CoV 2SARS Pneumonia+2 more
Hospital Departamental de Villavicencio
Not applicableNot Yet RecruitingNCT06534164
What this trial is testing

Telerehabilitation of Balance Clinical and Economic Decision Support System

Who this might be right for
StrokeMild Cognitive ImpairmentVestibular Diseases+1 more
University College, London 460
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Large-scale testing (Phase 3)WithdrawnNCT01177852
What this trial is testing

Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis

Who this might be right for
InflammationCoughRhinitis
Ache Laboratorios Farmaceuticos S.A.
Not applicableStudy completedNCT02853838
What this trial is testing

Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)

Who this might be right for
Bronchiolitis, Viral
Universidad del Desarrollo 204
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Testing effectiveness (Phase 2)Active Not RecruitingNCT06204432
What this trial is testing

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

Who this might be right for
Long Haul COVID-19Post-Acute COVID-19 SyndromeAnosmia+1 more
University of North Carolina, Chapel Hill 60
Not applicableUnknownNCT05815693
What this trial is testing

Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors

Who this might be right for
Post Acute COVID-19 Syndrome
Azienda Socio Sanitaria Territoriale di Lecco 140
Testing effectiveness (Phase 2)Study completedNCT04468009
What this trial is testing

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Who this might be right for
SARS-Associated CoronavirusCovid19SARS-CoV Infection
Hospital de Infecciosas Francisco Javier Muniz 134
Testing effectiveness (Phase 2)Temporarily pausedNCT04482621
What this trial is testing

Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial

Who this might be right for
COVID-19
Johns Hopkins University 33
Not applicableLooking for participantsNCT06928506
What this trial is testing

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Who this might be right for
Long COVIDPost COVID-19 ConditionPost Acute Sequelae of COVID-19
University Health Network, Toronto 120
Testing effectiveness (Phase 2)Study completedNCT04312009
What this trial is testing

Losartan for Patients With COVID-19 Requiring Hospitalization

Who this might be right for
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection
University of Minnesota 205
Not applicableNot Yet RecruitingNCT07694232
What this trial is testing

A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID

Who this might be right for
Long COVIDLong COVID Symptoms
St. Mary's University, Twickenham 120
Not applicableStudy completedNCT05652634
What this trial is testing

Chronic Stress as a Risk Factor for Long COVID

Who this might be right for
Long COVIDAcute COVID-19
Medical University of Graz 380
Next Page